Status:
RECRUITING
ACT for Mental Health in Neurological Disorders
Lead Sponsor:
Bielefeld University
Conditions:
Neurological Disorders
Mental Health
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to examine the efficacy of this manual for mental health in people with mixed neurological disorders, including post-COVID. These conditions are often associated wit...
Detailed Description
Mental health issues, especially depression, anxiety, and stress, are common in people with neurological disorders and post-COVID but often neglected and hence, remain untreated. Acceptance and Commit...
Eligibility Criteria
Inclusion
- Value above a cut-off of the DASS-21 subscales (depression \> 10, anxiety \> 6, and stress \> 10)
- Sufficient cognition and language ability (clinical rating)
- Sufficient therapy motivation (clinical rating)
Exclusion
- Behavioral disorders (e.g., high irritability or apathy in clinical rating)
- Other severe mental disorder (dementia, psychosis, personality disorders, intellectual disability)
- Simultaneous psychotherapy or neuropsychological therapy
Key Trial Info
Start Date :
December 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06897553
Start Date
December 1 2024
End Date
December 31 2026
Last Update
March 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neuropsychologische Hochschulambulanz Bielefeld
Bielefeld, Germany, 33602